^
8ms
New P1 trial • Metastases
|
Anniko (penpulimab) • TQB2223
over1year
TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers (clinicaltrials.gov)
P1, N=92, Recruiting, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
New P1 trial • Combination therapy • Metastases
|
LAG3 (Lymphocyte Activating 3)
|
Anniko (penpulimab) • TQB2223